• Port-a-Patch

    世界上最小的膜片钳系统
  • Port-a-Patch

    易学易用——教学的理想工具
  • Port-a-Patch

    可记录细胞、细胞器与脂双层
  • Port-a-Patch

    世界上首款平板芯片膜片钳设备
  • Port-a-Patch

    可进行内灌流——更换细胞内液的理想工具

hERG - "Characterization of hERG (CHO) on Nanion's Port-a-Patch"

icon pap   Port-a-Patch application note:   logo pdf   (0.6 MB)
Cells were kindly provided by Millipore.  

Summary:

The hERG gene (KCNH2) encodes a potassium ion channel responsible for the repolarizing IKr current in the cardiac action potential (Sanguinetti et al., 1995). Abnormalities in this channel may lead to either Long QT Syndrome (LQT2) (with loss-of-function mutations) or Short QT syndrome (with gain-of-function mutations), both potentially fatal cardiac arrhythmia, due to repolarization disturbances of the cardiac action potential. Given the importance of this channel in maintaining cardiac function, it has become an important target in compound safety screening. A large range of therapeutic agents with diverse chemical structures have been reported to induce long QT syndrome. These include antihistamines (e.g. Terfenadine), gastrointestinal prokinetic agents (e.g. Cisapride) and others. In this report we present data that were collected on the Port-a-Patch. Cells (CHO permanently expressing hERG, supplied by Millipore) were tested. Current amplitudes, IVs and cisapride as well as quinidine dose response curves were analyzed.

返回总览

We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.